Regions Financial Corp’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Buy
15,547
+1,157
+8% +$173K 0.01% 335
2026
Q1
$2.2M Sell
14,390
-1,986
-12% -$304K 0.01% 354
2025
Q4
$2.26M Sell
16,376
-437
-3% -$57.2K 0.01% 359
2025
Q3
$2.16M Buy
16,813
+11,580
+221% +$1.41M 0.01% 369
2025
Q2
$633K Sell
5,233
-274
-5% -$30.9K ﹤0.01% 568
2025
Q1
$614K Sell
5,507
-506
-8% -$53.9K ﹤0.01% 551
2024
Q4
$585K Buy
6,013
+105
+2% +$11.2K ﹤0.01% 560
2024
Q3
$680K Buy
5,908
+38
+0.6% +$4.31K ﹤0.01% 546
2024
Q2
$625K Sell
5,870
-549
-9% -$55.1K ﹤0.01% 547
2024
Q1
$621K Buy
6,419
+13
+0.2% +$1.33K ﹤0.01% 558
2023
Q4
$647K Sell
6,406
-41
-0.6% -$3.96K 0.01% 547
2023
Q3
$657K Buy
6,447
+775
+14% +$78.7K 0.01% 526
2023
Q2
$572K Sell
5,672
-691
-11% -$69.1K ﹤0.01% 562
2023
Q1
$585K Sell
6,363
-93
-1% -$8.12K 0.01% 564
2022
Q4
$585K Sell
6,456
-286
-4% -$24.1K 0.01% 569
2022
Q3
$513K Sell
6,742
-1,631
-19% -$135K 0.01% 569
2022
Q2
$708K Sell
8,373
-29,983
-78% -$2.63M 0.01% 532
2022
Q1
$3.37M Buy
38,356
+1,133
+3% +$98.1K 0.03% 282
2021
Q4
$3.26M Sell
37,223
-1,712
-4% -$142K 0.03% 295
2021
Q3
$3.18M Buy
38,935
+1,248
+3% +$112K 0.03% 289
2021
Q2
$3.44M Buy
37,687
+12,536
+50% +$1.12M 0.03% 278
2021
Q1
$2.15M Sell
25,151
-12,481
-33% -$1.12M 0.02% 327
2020
Q4
$3.55M Sell
37,632
-6,795
-15% -$594K 0.03% 251
2020
Q3
$3.86M Sell
44,427
-8,286
-16% -$718K 0.04% 216
2020
Q2
$4.6M Buy
52,713
+5,716
+12% +$493K 0.05% 191
2020
Q1
$3.88M Sell
46,997
-917
-2% -$81.8K 0.05% 203
2019
Q4
$4.54M Buy
47,914
+5,479
+13% +$492K 0.05% 216
2019
Q3
$3.69M Sell
42,435
-200
-0.5% -$18K 0.04% 220
2019
Q2
$3.89M Sell
42,635
-4,341
-9% -$367K 0.04% 216
2019
Q1
$4.05M Sell
46,976
-6,325
-12% -$508K 0.05% 207
2018
Q4
$4.1M Buy
53,301
+4,272
+9% +$333K 0.05% 196
2018
Q3
$3.79M Buy
49,029
+1,672
+4% +$124K 0.04% 219
2018
Q2
$3.21M Sell
47,357
-11,358
-19% -$784K 0.04% 229
2018
Q1
$4.25M Buy
58,715
+3,080
+6% +$234K 0.05% 204
2017
Q4
$4.18M Buy
55,635
+8,267
+17% +$624K 0.05% 205
2017
Q3
$3.64M Buy
47,368
+9,003
+23% +$680K 0.04% 213
2017
Q2
$2.87M Buy
38,365
+10,206
+36% +$723K 0.03% 238
2017
Q1
$1.87M Sell
28,159
-5,002
-15% -$333K 0.02% 318
2016
Q4
$2.16M Buy
33,161
+3,956
+14% +$257K 0.03% 269
2016
Q3
$2.07M Sell
29,205
-7,733
-21% -$564K 0.03% 281
2016
Q2
$2.73M Buy
36,938
+56
+0.2% +$3.87K 0.04% 216
2016
Q1
$2.39M Buy
36,882
+12,111
+49% +$824K 0.03% 250
2015
Q4
$1.91M Buy
24,771
+1,461
+6% +$116K 0.03% 318
2015
Q3
$1.92M Buy
23,310
+3,386
+17% +$301K 0.03% 319
2015
Q2
$1.76M Buy
19,924
+1,973
+11% +$181K 0.02% 357
2015
Q1
$1.59M Buy
17,951
+6,123
+52% +$543K 0.02% 392
2014
Q4
$982K Sell
11,828
-31,713
-73% -$2.63M 0.01% 519
2014
Q3
$3.67M Sell
43,541
-3,013
-6% -$244K 0.05% 224
2014
Q2
$3.78M Sell
46,554
-3,620
-7% -$285K 0.05% 229
2014
Q1
$3.82M Buy
50,174
+1,567
+3% +$114K 0.05% 218
2013
Q4
$3.5M Buy
48,607
+14,876
+44% +$1.03M 0.04% 238
2013
Q3
$2.32M Buy
33,731
+402
+1% +$26.6K 0.03% 293
2013
Q2
$2.11M Buy
+33,329
New +$2.17M 0.03% 287

Other funds holding NVS

Regions Financial Corp's NVS Position: Q2 2026 in Review

Regions Financial Corp increased its Novartis (NVS) stake by 8% in Q2 2026, buying an estimated $173K and bringing the position to 15,547 shares worth $2.44M. The position accounts for 0.01% of the portfolio, ranked #335.

Regions Financial Corp first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.6M in Q2 2020. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Regions Financial Corp held 15,547 shares of Novartis worth $2.44M as of Q2 2026.
  • Regions Financial Corp bought 1,157 Novartis shares in Q2 2026, an estimated $173K.
  • Novartis made up 0.01% of Regions Financial Corp's portfolio in Q2 2026, its #335 holding.
  • Regions Financial Corp first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Regions Financial Corp's Novartis position peaked at $4.6M in Q2 2020.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.